Baudax Bio Valuation

Baudax Bio Investor Information

The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Baudax Bio recorded a loss per share of 94.13. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 1st of December 2022. Based on the analysis of Baudax Bio's profitability, liquidity, and operating efficiency, Baudax Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Baudax Bio Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Baudax Bio has an asset utilization ratio of 12.65 percent. This suggests that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that Baudax Bio is more efficient with each dollar of assets it utilizes for everyday operations.

Baudax Bio Ownership Allocation

Baudax Bio holds a total of 43.59 Million outstanding shares. Almost 97.31 percent of Baudax Bio outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 2.68 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Baudax Bio Profitability Analysis

The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M).

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.